Plasma ceramides are altered in MCI and predict cognitive decline and hippocampal volume loss

BACKGROUND: A blood-based biomarker of Alzheimer disease (AD) would be superior to CSF and neuroimaging measures in terms of cost, invasiveness and feasibility for repeated measures. We previously reported blood ceramides varied in relation to timing of memory impairment in a population-based study....

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Mielke, Michelle M., Haughey, Norman J., Bandaru, Veera Venkata Ratnam, Schech, Steven, Carrick, Richard, Carlson, Michelle C., Mori, Susumu, Miller, Michael I., Ceritoglu, Can, Brown, Timothy, Albert, Marilyn, Lyketsos, Constantine G.
פורמט: Artigo
שפה:Inglês
יצא לאור: 2010
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC2933928/
https://ncbi.nlm.nih.gov/pubmed/20813340
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jalz.2010.03.014
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים